Blindness News and Research

RSS

A new strategy to combat treatment resistance in choroidal neovascularization

An international team of researchers led by Baylor College of Medicine and Houston Methodist has discovered a strategy that can potentially address a major challenge to the current treatment for choroidal neovascularization (CNV), an aggressive form of age-related macular degeneration, the leading cause of irreversible blindness in the elderly.

16 Jul 2020

Spectral notch filters in glasses enhance color vision for those with red-green CVD

A new UC Davis Eye Center study, conducted in collaboration with France's INSERM Stem Cell and Brain Research Institute, found that special patented glasses engineered with technically advanced spectral notch filters enhance color vision for those with the most common types of red-green color vision deficiency ("anomalous trichromacy").

14 Jul 2020

7-day levofloxacin/dexamethasone eye drops as effective as standard treatment after cataract surgery

Santen EMEA and NTC are delighted to announce that the results of their phase III clinical study, LEADER7, have been published in Eye.

13 Jul 2020

Face blindness may arise from deficits beyond visual perception

The ability to recognize faces is a complex neurocognitive skill with important social implications. The disorder, which, according to some estimates, affects more than 2 percent of the population, can lead to isolation and anxiety and impair personal and work relationships.

12 Jul 2020

Researchers use nanoparticles to deliver gene therapy for blinding eye disease

In experiments in rats and mice, two Johns Hopkins scientists - an engineer and an ophthalmologist - report the successful use of nanoparticles to deliver gene therapy for blinding eye disease.

7 Jul 2020

New nanoparticle-based artificial retina prosthesis restores vision in blind rats

An international team of scientists, of which the University of Granada (UGR) is a member, has developed a new nanoparticle-based artificial retina prosthesis that can be injected into the eye.

7 Jul 2020

Researchers develop artificial liquid retinal prosthesis to counteract the effects of eye disorders

Researchers at IIT-Istituto Italiano di Tecnologia (Italian Institute of Technology) has led to the revolutionary development of an artificial liquid retinal prosthesis to counteract the effects of diseases such as retinitis pigmentosa and age-related macular degeneration that cause the progressive degeneration of photoreceptors of the retina, resulting in blindness.

30 Jun 2020

Researchers develop a promising treatment to prevent blindness

The team was co-led by May Griffith, a researcher at Maisonneuve-Rosemont Hospital Research Centre, which is affiliated with Université de Montréal and is part of the CIUSSS de l'Est-de-l'Île-de-Montréal.

30 Jun 2020

New eye drops could prevent vision loss after retinal vein occlusion

Researchers at Columbia University Irving Medical Center have developed eye drops that could prevent vision loss after retinal vein occlusion, a major cause of blindness for millions of adults worldwide.

29 Jun 2020

New method spurs production of antibiotic or antiparasitic compounds in actinobacteria

Researchers have developed a method to spur the production of new antibiotic or antiparasitic compounds hiding in the genomes of actinobacteria, which are the source of drugs such as actinomycin and streptomycin and are known to harbor other untapped chemical riches.

25 Jun 2020

Hungarian physician to receive the Körber Prize for European Science 2020

The Körber Prize for European Science 2020, which is endowed with one million euros, is being awarded to the Hungarian physician Botond Roska.

23 Jun 2020

Fractured skulls, lost eyes: Police often break own rules using ‘rubber bullets’

Megan Matthews thought she was dying. "I thought my head was blown off," said Matthews, 22, who was hit in the eye with a sponge-tipped projectile fired by law enforcement at a May 29 protest in Denver. "Everything was dark. I couldn't see."

19 Jun 2020

Study reveals new insight into Fuchs’ endothelial corneal dystrophy

The molecular changes that lead to Fuchs' endothelial corneal dystrophy (FECD) occur decades before the disease causes blurry vision and other noticeable symptoms in patients, new research by UT Southwestern scientists shows.

17 Jun 2020

Researchers question the mechanism of retinitis pigmentosa

Researchers who made a knock-in mouse-model of the genetic disorder retinitis pigmentosa 59, or RP59, expected to see retinal degeneration and retinal thinning. As reported in the journal Cells, they surprisingly found none, calling into question the commonly accepted -- though never proved -- mechanism for RP59.

12 Jun 2020

Researchers use human stem cell models to analyze degeneration in glaucoma

More than 3 million Americans have glaucoma, a serious eye condition causing vision loss. Using human stem cell models, researchers at Indiana University School of Medicine found they could analyze deficits within cells damaged by glaucoma, with the potential to use this information to develop new strategies to slow the disease process.

11 Jun 2020

Treatment with vitamin A analog improves visual function in diabetic mice

Diabetic retinopathy is a common complication of diabetes and a leading cause of blindness among the working-age population.

11 Jun 2020

Experts clarify MS subtypes to improve care and access to treatments

An international committee of multiple sclerosis (MS) experts has clarified their previously published descriptors of the different courses of MS and disease activity.

11 Jun 2020

Santen Pharmaceutical and jCyte conclude an exclusive licensing contract in Japan, Asia and Europe for the jCell therapy programme for retinitis pigmentosa

Santen Pharmaceutical Co., Ltd. and jCyte Inc. announced the conclusion of an exclusive licensing contract covering the development, registration and commercialisation rights in Japan, Asia and Europe to jCell, a first-in-class investigational therapy, currently in clinical development for retinitis pigmentosa.

From Santen Pharmaceutical Co., Ltd. 9 Jun 2020

Oxidative stress and growth factors associated with development of high myopia

According to the first world report on vision published by the WHO in 2019, a third of the planet's population suffers from myopia, and around 400 million people suffer the most harmful version of the disease: high myopia.

4 Jun 2020

People with sight loss are greatly affected by Covid-19 pandemic, survey shows

A survey by eye research charity Fight for Sight has found that people with sight loss fear their sight will further deteriorate during the Covid-19 pandemic, as they struggle to access treatment for their eye conditions.

4 Jun 2020

Blindness News and Research

A new strategy to combat treatment resistance in choroidal neovascularization

Spectral notch filters in glasses enhance color vision for those with red-green CVD

7-day levofloxacin/dexamethasone eye drops as effective as standard treatment after cataract surgery

Face blindness may arise from deficits beyond visual perception

Researchers use nanoparticles to deliver gene therapy for blinding eye disease

New nanoparticle-based artificial retina prosthesis restores vision in blind rats

Researchers develop artificial liquid retinal prosthesis to counteract the effects of eye disorders

Researchers develop a promising treatment to prevent blindness

New eye drops could prevent vision loss after retinal vein occlusion

New method spurs production of antibiotic or antiparasitic compounds in actinobacteria

Hungarian physician to receive the Körber Prize for European Science 2020

Fractured skulls, lost eyes: Police often break own rules using ‘rubber bullets’

Study reveals new insight into Fuchs’ endothelial corneal dystrophy

Researchers question the mechanism of retinitis pigmentosa

Researchers use human stem cell models to analyze degeneration in glaucoma

Treatment with vitamin A analog improves visual function in diabetic mice

Experts clarify MS subtypes to improve care and access to treatments

Santen Pharmaceutical and jCyte conclude an exclusive licensing contract in Japan, Asia and Europe for the jCell therapy programme for retinitis pigmentosa

Oxidative stress and growth factors associated with development of high myopia

People with sight loss are greatly affected by Covid-19 pandemic, survey shows

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News